Loading...
*  Cervarix (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022: Reportstack
The first prophylactic vaccine for immunization against human papillomavirus (HPV) became available in 2006. The global HPV ... Cervarix (Prophylactic Human PapillomaVirus Vaccines) - Forecast and Market Analysis to 2022 is a new market research ... To view the table of contents and know more details please visit Cervarix (Prophylactic Human PapillomaVirus Vaccines) - ... The current HPV vaccines market is dominated by one major player, Merck's Gardasil, with GlaxoSmithKline's (GSK's) HPV vaccine ...
https://pitchengine.com/pitches/e1e049fe-2d46-42cf-8d96-daee448b9535
*  Human papillomavirus vaccine uptake annual survey 2010/11 - GOV.UK
... uptake coordinators on how to determine the annual denominators and enter the vaccine uptake data. ... Guidance for primary care trust human papillomavirus vaccine (HPV) ... Download Human Papillomavirus vaccine uptake annual survey 2010-11 PDF, 597KB, 10 pages ... Guidance for primary care trust human papillomavirus vaccine (HPV) uptake coordinators on how to determine the annual ...
https://www.gov.uk/government/publications/human-papillomavirus-vaccine-uptake-annual-survey-2010-11
*  Human papillomavirus vaccine introduction--the first five years. - NextBio article
Papillomavirus Vaccines human papillomavirus vaccine L1, type 6,11,16,18 human papillomavirus vaccine, L1 type 16, 18 ... Human papillomavirus vaccine introduction--the first five years. Vaccine. 2012 Nov 20;30 Suppl 5:F139-48 ... Human papillomavirus vaccine introduction--the first five years. Lauri E Markowitz, Vivien Tsu, Shelley L Deeks, Heather Cubie ... The availability of prophylactic human papillomavirus (HPV) vaccines has provided powerful tools for primary prevention of ...
http://www.nextbio.com/b/search/article.nb?id=23199957
*  Frontiers | Determinants in the Uptake of the Human Papillomavirus Vaccine: A Systematic Review Based on European Studies |...
Since 2006, two Human Papillomavirus vaccines (HPVV ) have been licensed to protect women against the virus that causes ... Conclusions Since the vaccine is offered for free in most of the European countries, the findings suggest that ethno-cultural ... Girls who were undervaccinated had also a lower uptake of standard childhood vaccines and mothers who were less likely to ... Since 2006, two Human Papillomavirus vaccines (HPVV ) have been licensed to protect women against the virus that causes ...
https://www.frontiersin.org/articles/10.3389/fonc.2015.00141/full
*  VM -- Development of the Human Papillomavirus Vaccine and Guidelines for Its Use, Jan 07 ... Virtual Mentor
A physician explains the human papillomavirus vaccine and guidelines for its use. Virtual Mentor is a monthly bioethics journal ... Development of the Human Papillomavirus Vaccine and Guidelines for Its Use. A physician explains the human papillomavirus ... Prophylactic quadrivalent human papillomavirus (type 6, 11, 16 and 18) L1 virus-like particle vaccine in young women: a ... The future of the HPV vaccine. Vaccination against the human papillomavirus is an exciting advancement in the war against ...
http://virtualmentor.ama-assn.org/2007/01/cprl1-0701.html
*  Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event...
... a case-control assessment of the vaccine adverse events. ... Gardasil is a quadrivalent human papillomavirus (HPV4) vaccine ... Quadrivalent human papillomavirus vaccine and autoimmune adverse events: ... Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event ... Quadrivalent human papillomavirus vaccine and autoimmune adverse events: a case-control assessment of the vaccine adverse event ...
http://sanevax.org/autoimmune-adverse-events/
*  Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission...
Jit, M; Brisson, M; Laprise, JF; Choi, YH; (2015) Comparison of two dose and three dose human papillomavirus vaccine schedules ... Two dose human papillomavirus vaccine schedules are likely to be the most cost effective option provided protection lasts for ... No, two, or three doses of human papillomavirus vaccine given routinely to 12 year old girls, with an initial catch-up campaign ... Two dose schedules for bivalent or quadrivalent human papillomavirus vaccines were assumed to provide 10, 20, or 30 years' ...
http://researchonline.lshtm.ac.uk/2180380/
*  Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine. - AdisInsight
This observational post-marketing study investigated the tolerability of human papillomavirus vaccine in pregnant women for the ... Drugs Human papillomavirus vaccine (Primary) * Indications Anal cancer; Anal intraepithelial neoplasia; Cervical cancer; ... Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine. Next ... Final report on exposure during pregnancy from a pregnancy registry for quadrivalent human papillomavirus vaccine. Completed ...
http://adisinsight.springer.com/trials/700264268?error=cookies_not_supported&code=0b7013e7-3f39-4aee-b85b-90f0f512b4f5
*  Authority of Pharmacists to Administer Human Papillomavirus Vaccine: Alignment of State Laws With Age-Level Recommendations ...
One strategy to increase the uptake of human papillomavirus (HPV) vaccine among adolescents is through the use of pharmacists. ... phr.sagepub.com/content/current Research Authority of Pharmacists to Administer Human Papillomavirus Vaccine: Alignment of ... vaccines and global health :: ethics and policy. …..from the Center for Vaccine Ethics and Policy. Menu. Skip to content ... Authority of Pharmacists to Administer Human Papillomavirus Vaccine: Alignment of State Laws With Age-Level Recommendations One ...
https://centerforvaccineethicsandpolicy.net/2018/01/13/authority-of-pharmacists-to-administer-human-papillomavirus-vaccine-alignment-of-state-laws-with-age-level-recommendations/
*  Cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine to cervical cancer...
... type 16 prophylactic vaccine. Vaccine. 2007, 25: 4324-4333. 10.1016/j.vaccine.2007.02.069.View ArticlePubMedGoogle Scholar. ... 10.1016/j.vaccine.2007.07.018.View ArticlePubMedGoogle Scholar. *. Olsen J, Jepsen MR: Human papillomavirus transmission and ... The potential cost-effectiveness of prophylactic human papillomavirus vaccines in Canada. Vaccine. 2007, 25: 5399-5408. 10.1016 ... Structural differences among cost-effectiveness models of human papillomavirus vaccines. Expert Rev Vaccines. 2008, 7: 895-913 ...
https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-12-924
*  The Role of Imiquimod 3.75% Cream in the Treatment of External Genital Warts
Human papillomavirus, genital warts, and vaccines. J Microbiol Immunol Infect. 2009 Apr;42(2):101-6. ... Human PapillomaVirus. Arch Dermatol. 1998 Jan;134(1):25-30.. *Zyclara cream, 3.75% [prescribing information]. Graceway ... Wiley D, Masongsong E. Human papillomavirus: the burden of infection. Obstet Gynecol Surv. 2006 Jun;61(6 Suppl 1):S3-14. ... The psychosocial impact of human papillomavirus infection: implications for health care providers. Int J STD AIDS. 1996 May-Jun ...
http://www.skintherapyletter.com/2012/17.4/2.html
*  Prophylactic human papillomavirus vaccines. - PubMed - NCBI
Prophylactic human papillomavirus vaccines.. Lowy DR1, Schiller JT.. Author information. 1. Laboratory of Cellular Oncology, ... The Merck vaccine also targets HPV6 and HPV11, which account for approximately 90% of external genital warts. The vaccines have ... Merck and GlaxoSmithKline are developing commercial versions of the vaccine. Both vaccines target HPV16 and HPV18, which ... Human papillomavirus (HPV) infection causes virtually all cases of cervical cancer, the second most common cause of death from ...
https://www.ncbi.nlm.nih.gov/pubmed/16670757?dopt=Abstract
*  Human Papillomavirus Vaccines
Pathobiology and immunology of human papillomavirus Margaret Stanley. *Overview of clinical evidence: the quadrivalent vaccine ... The two commercially available vaccines against human papillomavirus (HPV) infection are very effective in preventing ... The vaccines are very effective in preventing infections with the two major cancer-causing genotypes, HPV-16 and HPV-18, and ... HPV vaccines: public health and clinical guidelines F Xavier Bosch. *Perspectives for prophylactic and therapeutic vaccination ...
http://www.future-science-group.com/shop/human-papillomavirus-vaccines/
*  Human Papillomavirus Vaccine (Intramuscular Route) Side Effects - Mayo Clinic
Human papillomavirus (HPV) vaccine is an active immunizing agent used to prevent infection caused by human papillomavirus. It ... Information about this human-papillomavirus-vaccine-intramuscular-route. Pregnancy Category. Explanation. All Trimesters. B. ... Appropriate studies on the relationship of age to the effects of human papillomavirus vaccine have not been performed in the ... Appropriate studies have not been performed on the relationship of age to the effects of human papillomavirus vaccine in ...
https://www.mayoclinic.org/drugs-supplements/human-papillomavirus-vaccine-intramuscular-route/side-effects/drg-20127679?p=1
*  Global Prophylactic Human PapillomaVirus Vaccines Industry Research: RnRMarketResearch.com - Market Research Reports Store
"PharmaPoint: Prophylactic Human PapillomaVirus Vaccines - Current and Future Players". The report is a vital source of up-to- ... The report identifies and analyses the key companies shaping and driving the global Prophylactic Human Papillomavirus Vaccines ... What's the next big thing in the global Prophylactic Human Papillomavirus Vaccines market landscape? Identify, understand and ... Gain a high level view of the trends shaping and driving Prophylactic Human Papillomavirus Vaccines market ...
https://pitchengine.com/pitches/ef2a0b89-5a97-4f18-b3fb-903046d77e03
*  Human Papillomavirus Vaccine: A New Chance to Prevent Cervical Cancer | SpringerLink
Human papillomavirus (HPV) is a significant source of morbidity and mortality throughout the world and is the most common ... A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 347:1645-1651PubMedCrossRefGoogle Scholar ... Steinbrook R (2006) The potential of human papillomavirus vaccines. N Engl J Med 354:1109-1112PubMedCrossRefGoogle Scholar ... Jansen KU, Shaw AR (2004) Human papillomavirus vaccines and prevention of cervical cancer. Annu Rev Med 55:319-331PubMed ...
https://link.springer.com/chapter/10.1007/978-3-540-37696-5_8
*  Quadrivalent Human Papillomavirus Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Quadrivalent Human Papillomavirus Vaccine Composition The licensed vaccine is a quadrivalent HPV vaccine (GARDASILTM, produced ... Vaccine 2006;24:S178--S186.. * Sanders GD, Taira AV. Cost-effectiveness of a potential vaccine for human papillomavirus. Emerg ... Vaccines for Children Program The Vaccines for Children (VFC) program supplies vaccines to all states, territories, and the ... Interrupted Vaccine Schedules If the quadrivalent HPV vaccine schedule is interrupted, the vaccine series does not need to be ...
https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5602a1.htm?s_cid=rr5602a1_e
*  Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines. - PubMed - NCBI
Chimeric L1-L2 virus-like particles as potential broad-spectrum human papillomavirus vaccines.. Schellenbacher C1, Roden R, ... Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines ... Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines ... Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines ...
https://www.ncbi.nlm.nih.gov/pubmed/19640991
*  Human papillomavirus vaccine and pregnancy. - NextBio article
Papillomavirus Vaccines Vaccines, Inactivated human papillomavirus vaccine L1, type 6,11,16,18 ... Human papillomavirus vaccine and pregnancy. Canadian family physician Médecin de famille canadien. 2012 Mar;58(3):268-9 ... What is known about the safety of the HPV vaccine during pregnancy? The HPV vaccine is generally not recommended for use in ... However, theoretically, because it is not a live vaccine, it is not expected to be associated with an increased risk. Also, ...
http://www.nextbio.com/b/search/article.nb?id=22423020
*  European Medicines Agency - Human medicines - Human papillomavirus vaccines - Cervarix, Gardasil, Gardasil 9, Silgard
Bivalent human papillomavirus vaccine and the risk of fatigue syndromes in girls in the UK. Vaccine 2013; 31: 4961-7. ... in young women given human papillomavirus (HPV) vaccines. These vaccines are given to protect them from cervical cancer and ... HPV vaccines - Article-20 procedure - Notification HR = Hrvatski 2015-07-13 HPV vaccines - Article-20 procedure - Timetable for ... Human papillomavirus vaccines - Cervarix, Gardasil, Gardasil 9, Silgard. International non-proprietary name (INN) or common ...
http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/referrals/Human_papillomavirus_vaccines/human_referral_prac_000053.jsp&mid=WC0b01ac05805c516f
*  Department of Health | Planning for human papillomavirus vaccines in Australia: Report of a research group meeting
Whilst most infection resolves without symptoms, some human papillomavirus infections can persist and cause cancer. ... Number 2 discusses human papillomavirus (HPV) which is the most common viral sexually transmitted infection, with estimates ... Planning for human papillomavirus vaccines in Australia: Report of a research group meeting. This report published in ... Potential health and economic impact of adding a human papillomavirus vaccine to screening programs. JAMA 2003;290:781-789. 12 ...
http://www.health.gov.au/internet/main/publishing.nsf/Content/cda-pubs-cdi-2004-cdi2802-htm-cdi2802p.htm
*  Human Papillomavirus Vaccine - Infectious Diseases - Merck Manuals Professional Edition
Learn about Human Papillomavirus Vaccine from the Home Version of the Merck Manuals. ... Human Papillomavirus Vaccine By William D. Surkis, MD, Clinical Associate Professor of Medicine;Director, Internal Medicine ... A new vaccine that is effective against 9 types of HPV will soon be available. The new vaccine covers the same types of HPV as ... A quadrivalent vaccine (HPV4) that protects against 4 types of HPV: types 6 and 11, which cause > 90% of visible genital warts ...
http://www.merckmanuals.com/en-ca/professional/infectious-diseases/immunization/human-papillomavirus-vaccine
*  Papillomavirus Vaccine May Reduce Vulval And Vaginal Cancers - BioTech Weblog
Papillomavirus Vaccine May Reduce Vulval And Vaginal Cancers 0 By Ruth on May 20, 2007. · Drugs, Vaccines and Therapeutics ... You are at:Home»Drugs, Vaccines and Therapeutics»Papillomavirus Vaccine May Reduce Vulval And Vaginal Cancers ... Vaccine efficacy varied from 71% in women previously exposed to the human papillomaviruses to 100% in those not previously ... According to a recent study, a quadrivalent human papillomavirus (HPV) vaccine is effective in preventing high-grade vulval and ...
http://www.biotech-weblog.com/papillomavirus-vaccine-may-reduce-vulval-and-vaginal-cancers/
*  Human Papillomavirus Vaccine in Cutaneous Basaloid Squamous Cell Carcinomas - The ASCO Post
Human Papillomavirus Vaccine in Cutaneous Basaloid Squamous Cell Carcinomas. By The ASCO Post. Posted: 7/13/2018 11:06:36 AM. ... The patient was first given two doses of the 9-valent HPV vaccine (Gardasil 9) in her arm, 6 weeks apart. A few weeks later Dr ... Tim Ioannides, MD, a voluntary faculty member at UM, suggested using the vaccine as an off-label treatment by directly ... Nichols showed the quadrivalent HPV vaccine (Gardasil) reduced the number of new basal and squamous cell skin cancers in 2 ...
http://ascopost.com/News/59054
*  Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection - Full Text View - ClinicalTrials.gov
Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection. The safety and scientific validity of this study is ... RATIONALE: Vaccines made from human papillomavirus may help the body build an effective immune response to kill HIV cells. ... A Single-Arm, Open-Label Pilot Trial of the Safety and Immunogenicity of a Quadrivalent Human Papillomavirus Vaccine in HIV-1- ... PURPOSE: This phase II trial is studying the side effects and how well human papillomavirus vaccine therapy works in treating ...
https://clinicaltrials.gov/show/NCT00513526?order=35